Heather Bresch defends Mylan on prices and profits, while FDA is asked “where’s the competition?
A significant airlines and allergies report was released in Canada this summer, and it does not contain good news for those of us concerned about adequate anaphylaxis readiness in the skies.
Amid a firestorm of controversy over price hikes on lifesaving EpiPens, drug manufacturer Mylan made a dramatic and unusual move this week – it announced the launch of a lower cost generic replica of its own brand-name epinephrine auto-injector.
Mylan announced on Aug. 29 that it will launch a generic version of its EpiPen at half the cost of the patented original.
Study finds “bad habits” may ward off allergies to cats, dust mites, mold and more.
Dr. Scott Commins explains how tick-related meat allergy has spread, the role of animal fat in bad reactions, and promising progress toward a treatment.
The U.S. Department of Justice has found that a theater company violated a food-allergic boy’s rights.
Mother warns of precautions and communication needed to prevent tragedies like her daughter’s.
If you felt a sense of trepidation after reading the results of the new LEAP-On follow-up study, you’re not alone – many people in the food allergy community are going through a bout of culture shock. There’s no denying that the results of 2015’s LEAP and this month’s LEAP-On are quite phenomenal – a 74… Read more »
Exposure comes from touching surfaces and then accidentally ingesting peanut, researchers say.